Considering this and the apparent mitochondrial alterations in kidney cancer we selected for further validation two mitochondrial proteins (prohibitin, PRDX3) which we found as differentially expressed in our 2D-DIGE approach, and the S100-A9 protein. This evidence concerns the gene S100A9 and kidney cancer.